AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

5 Out of 5 (4446 Reviews)

I always feared medical emergencies, but KSquare helped us prepare financially. The SIP plan ensures liquidity when required. Now health issues don’t create financial panic anymore. Truly thoughtful solutions.

Nitin Patil

Nitin Patil

KSquare helped me take my first investment step confidently. I love how easy and flexible their SIP plans are, and the customer care is fantastic.

Simran Kaur

Simran Kaur

Content Writer

KSquare provides a transparent and smooth mutual fund experience. Their portfolio tools are user-friendly, and I love how effortless it feels to invest monthly.

Ritesh Bansal

Ritesh Bansal

Mechanical Engineer

I never explored NFOs until KSquare simplified the process. Their breakdown of fund objectives helped me make confident decisions as a first-time investor.

Meera Sood

Meera Sood

Interior Decorator

Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.

Harsh Mehta

Harsh Mehta

I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.

Manish Talreja

Manish Talreja

Sales Head

KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!

Rahul Nanda

Rahul Nanda

IT Consultant

KSquare’s guidance was top-tier. I felt informed and in control during the entire loan process. Truly reliable.

Meenal Shah

Meenal Shah

Content Manager

Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.

Rohit Verma

Rohit Verma

Marketing Consultant

KSquare made the loan process so efficient that I didn’t feel stressed at all. Fantastic customer support as well.

Riya Bhattacharya

Riya Bhattacharya

Brand Consultant

FAQ's

Frequenlty Asked Question

How do I choose the right asset allocation in NPS?

KSquare helps you select between Active and Auto choices based on your age, risk appetite, and retirement goals.

Will I still earn returns on pledged mutual funds?

Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.

Does KSquare provide medical emergency fund planning?

Yes, KSquare builds dedicated SIP plans focused on medical security so unexpected health expenses don’t affect regular finances.

How is an NFO different from regular mutual fund schemes?

Unlike existing funds with track records, NFOs offer fresh investment opportunities, often at a face value of ₹10.

Is NPS a good option for retirement planning?

Yes, NPS offers disciplined savings, market-linked returns, and tax benefits, making it a strong choice for long-term retirement planning.

Will I get tax benefits through SIP investments?

Yes, SIPs in ELSS funds qualify for tax deductions under Section 80C up to ₹1.5 lakh annually.

How do I manage taxes on my investments as an NRI?

KSquare provides tax guidance specific to NRIs, helping you plan and stay compliant with Indian tax laws.

Can I set up automatic investments through KSquare?

Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.

App Store